🏥
🏥 Health
Ozempic may lower cancer risk — but headlines are misleading, doctor warns
Several studies suggest that GLP-1 drugs such as Ozempic may reduce the risk of certain cancers, but doctors caution against over-interpreting the headlines. The apparent benefit may stem from the profile of the patients taking these drugs — those who are healthier, wealthier and have better access to healthcare — rather than from the drug itself. Physicians warn that media claims about Ozempic as a cancer treatment are likely significantly overstated.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!